Exploring metabolism and thinking in schizophrenia
Part of Mental health clinical trials.
This trial looks at how a natural chemical pathway in the body might relate to thinking problems in people with schizophrenia. It compares healthy volunteers to people with schizophrenia to find biological clues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy volunteer (no psychiatric or major medical conditions)
- Your age, sex, and education level should match a group of people with schizophrenia (this will be decided by the study team)
- You must be of Han Chinese ethnicity
- You cannot have any current mental health condition or be taking any psychiatric medications
- You must not have a family history of mental illness across three or more generations
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at tiny particles called exosomes in your blood and how small molecules inside them called microRNAs may affect thinking and memory in people with a first episode of schizophrenia. If you join, your blood will be used to help find new ways to understand and treat cognitive symptoms.
This study looks at brain chemicals involved in “glutamate” and “GABA” signaling in people with schizophrenia (and separately in healthy volunteers). It may help researchers understand what’s going wrong in the brain and guide future treatments.
This study looks at how the nervous system and energy pathways in your body work in people with schizophrenia. It aims to find differences that could help improve future treatments.
This study investigates how much mental effort people with psychotic disorders (like schizophrenia) use during thinking tests, compared to people without mental health conditions. It may help researchers better understand cognitive challenges in these disorders.
This study uses brain scans (MRI and PET) to look at energy use and a brain chemical called glutamate in people with schizophrenia. It compares healthy volunteers to those with well-controlled schizophrenia and those with hard-to-treat schizophrenia to understand the biology better.
This study uses brain scans and real-life surveys to understand how people with or without schizophrenia make decisions. It may help researchers learn how the brain works differently in schizophrenia.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.